UBX
Closed
Unity Biotechnology Inc
1.45
-0.07 (-4.61%)
Last Update: 06 Sep 2024 23:00:00
Yesterday: 1.52
Day's Range: 1.44 - 1.53
Send
sign up or login to leave a comment!
When Written:
1.85
Unity Biotechnology Inc. is a biotechnology company that focuses on developing therapeutics to extend human healthspan by targeting senescent cells. Senescent cells are cells that have stopped dividing and accumulate with age, contributing to age-related diseases such as osteoarthritis, pulmonary fibrosis, and age-related macular degeneration. Unity Biotechnology's approach involves developing small molecule drugs that selectively eliminate senescent cells, thereby preventing or reversing age-related diseases. The company was founded in 2011 and is headquartered in San Francisco, California. Unity Biotechnology went public in 2018 and is listed on the NASDAQ stock exchange under the ticker symbol "UBX".
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!